NCM
BNTX icon

Noesis Capital Mangement’s BioNTech BNTX Stock Holding History

Noesis Capital Mangement’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,500
Closed -$228K – 132
2025
Q1 		$228K Hold
2,500
– – 0.05% 115
2024
Q4 		$285K Hold
2,500
– – 0.05% 94
2024
Q3 		$297K Hold
2,500
– – 0.06% 95
2024
Q2 		$201K Hold
2,500
– – 0.04% 105
2024
Q1 		$231K Hold
2,500
– – 0.05% 85
2023
Q4 		$264K Hold
2,500
– – 0.06% 87
2023
Q3 		$272K Hold
2,500
– – 0.07% 82
2023
Q2 		$270K Hold
2,500
– – 0.07% 89
2023
Q1 		$311K Buy
+2,500
New +$343K 0.08% 79

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Noesis Capital Mangement's BNTX Position: Q2 2025 in Review

Noesis Capital Mangement sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 2,500 shares — an estimated $228K sold.

Noesis Capital Mangement first reported a position in BNTX in Q1 2023 and held it in 9 quarters. The position peaked at $311K in Q1 2023. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Noesis Capital Mangement reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Noesis Capital Mangement sold 2,500 BioNTech shares in Q2 2025, an estimated $228K.
  • Noesis Capital Mangement first reported a position in BioNTech in Q1 2023 and held it in 9 quarters.
  • Noesis Capital Mangement's BioNTech position peaked at $311K in Q1 2023.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Noesis Capital Mangement's 13F filing for Q2 2025, filed 4 Aug 2025.